Syndrome of inappropriate antidiuretic hormone secretion (SIADH)

Last updated: June 10, 2025

Syndrome of inappropriate antidiuretic hormone secretion (SIADH)

Watch later

Watch later

Anatomy of the heart
Anatomy clinical correlates: Heart
Erythropoietin
Cardiac work
Lymphatic system anatomy and physiology
Oncogenes and tumor suppressor genes
Human herpesvirus 8 (Kaposi sarcoma)
Cardiac cycle
Stroke volume, ejection fraction, and cardiac output
Action potentials in myocytes
Coronary circulation
Cardiovascular system anatomy and physiology
Anatomy of the coronary circulation
Pressures in the cardiovascular system
Baroreceptors
Chemoreceptors
Resistance to blood flow
Glucocorticoids
Hypertension: Pathology review
Essential hypertension: Clinical sciences
Aneurysms
Coronary artery disease: Pathology review
Coronary artery disease: Clinical sciences
Acute coronary syndrome: Clinical sciences
Heart failure
Angina pectoris
Atherosclerosis and arteriosclerosis: Pathology review
Peripheral artery disease
Androgens and antiandrogens
Cor pulmonale
Cortisol
Arterial disease
Peripheral artery disease: Pathology review
Antidiuretic hormone
Thyroid hormones
Adrenocorticotropic hormone
Parathyroid hormone
Growth hormone and somatostatin
Growth hormone deficiency
Synthesis of adrenocortical hormones
Adrenal hormone synthesis inhibitors
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Disorders of sexual development and sex hormones: Pathology review
Diabetes insipidus and SIADH: Pathology review
Pituitary tumors: Pathology review
Endocrine system anatomy and physiology
Phosphate, calcium and magnesium homeostasis
Cushing syndrome and Cushing disease: Pathology review
Progestins and antiprogestins
Prolactinoma
Glucagon
Electrolyte disturbances: Pathology review
Introduction to the central and peripheral nervous systems
Introduction to the somatic and autonomic nervous systems
Introduction to the skeletal system
Introduction to the muscular system
Anatomy of the limbic system
Anatomy clinical correlates: Cerebral hemispheres
Anatomy of the cerebellum
Anatomy clinical correlates: Cerebellum and brainstem
Vessels and nerves of the vertebral column
Anatomy of the ascending spinal cord pathways
Anatomy of the descending spinal cord pathways
Gluconeogenesis
Resting membrane potential
Cell signaling pathways
Transcription of DNA
Translation of mRNA
DNA damage and repair
Inheritance patterns
Hypoxia
Ischemia
Type I hypersensitivity
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Skin cancer: Pathology review
Amnesia, dissociative disorders and delirium: Pathology review
Mood disorders: Pathology review
Developmental and learning disorders: Pathology review
Anatomy of the thyroid and parathyroid glands
Estrogen and progesterone
Testosterone
Hunger and satiety
Insulin
Somatostatin
Oxytocin and prolactin

Flashcards

Syndrome of inappropriate antidiuretic hormone secretion (SIADH)

0 of 12 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 3 complete

Start
A 65-year-old man is brought to the emergency department because of nausea, vomiting, muscle weakness, and confusion. The symptoms began two days ago. Review of his medical record reveals that he has a recent diagnosis of depression for which fluoxetine therapy was initiated four-weeks ago by his psychiatrist. Temperature is 37.2°C (99°F), pulse is 78/min, and respiratory rate is 15/min and blood pressure is 117/78 mmHg. On physical examination, the patient has difficulty standing due to generalized weakness. Laboratory studies are as follows:    

 Laboratory value  Result  Reference Range 
 Sodium  118 mEq/L  136-146 mEq/L 
 Blood Urea Nitrogen  15 mg/dL  7-18 mg/dL 
 Creatinine  0.8 mg/dL  0.6-1.2 mg/dL 
 Glucose  105 mg/dL  70-110 mg/dL 
 Serum Osmolarity   241 mOsm/kg  275-295 mOsm/kg 
 Urine Osmolality  405 mOsm/kg  50-1,400 mOsm/kg 
     
The patient is provided with an infusion of 3% saline. Which of the following is a potential complication when using this solution

Transcript

Watch video only

Content Reviewers

How does your body know when to retain fluids and when to get rid of them?

It’s not like you just think to yourself “I’ve had too much water, better get rid of some.” (If you do, and it works, call us).

Your body uses chemicals called hormones to send widespread messages, kind of like how the P.A. system at school tells everyone to ignore the smoke billowing out of the science wing.

The antidiuretic hormone, abbreviated as ADH, is the hormone that controls water retention in the body.

It also constricts blood vessels, and incidentally the vasoconstrictor drug called vasopressin is just ADH. Cool! But that’s not what we’re talking about right now.

Anyways, the more ADH floating around in your blood, the more fluid you retain.

The less ADH in your blood, the more fluid you excrete.

The nephrons in the kidneys are the structures that physically control how much water is excreted from your body.

Nephrons are mostly a series of tubes attached end-to-end that type fluids and wastes towards the bladder.

These tubes though also allow fluids and electrolytes to move through the tube walls and back into the blood if needed.

ADH affects the last two-thirds of these tubes, called the distal convoluted tubule and the collecting ducts.

These tubes focus almost exclusively on reabsorbing water back into the blood.

The wall of these tubes are unsurprisingly made up of cells, a common trait of living things, but these cells have proteins called aquaporins.

Aquaporins allow water to move quickly in and out of the cells.

The more ADH floating around in the blood, the more aquaporins are available to... ahem...facilitate water movement through the cell (yo, wata, come over here for a sec).

So when ADH is low, most of the water flows through the distal convoluted tubule and the collecting duct, giving us diluted urine.

When ADH is high, aquaporins grab much of the water passing through the these tubes and throws them back into the blood.

When I drink a glass of water and that water is absorbed into my blood, my plasma osmolality drops, which means I’m diluting my blood with the water.

That means there’s more fluid for all those blood cells to bounce around in (wooo parrttayy).

The part of my brain called the hypothalamus sees this drop in plasma osmolality and tells the pituitary gland to slow down the release of ADH (that’s enough!).

Low ADH leads to lots of diluted urine (urine with low osmolality), which brings our plasma osmolality back to normal. What a nifty feedback loop.

Now suppose ADH continues to be released even though my plasma osmolality has dropped (stop it! STOP IT! pituitary gland whistling).

We’re going to continue retaining water, and as we drink more and more water, we might expect our plasma osmolality to continue dropping. However this isn’t exactly the case.

As more water is retained, it dilutes the other solutes floating around in our blood, like sodium.

The extra fluid also takes up more space in our blood vessels.

This taking up more space issue triggers another mechanism in our body that causes the hormone aldosterone to stop being released.

Less aldosterone floating around in the blood causes the body to start dumping sodium from the blood into the urine.

Concentration gradients cause water to follow sodium, so we end up with the excess water being excreted in the urine with the sodium, normalizing the fluid volume in the blood.

So now our body is removing sodium from blood that already has a lower concentration of sodium. Uh oh!

This means the plasma sodium osmolarity is dropping significantly.

This whole fiasco we’ve just talked about is called syndrome of inappropriate antidiuretic hormone, often abbreviated as SIADH.

Key Takeaways

Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is characterized by excessive release of antidiuretic hormone from the posterior pituitary gland or another source. The increase in fluid retention often results in dilutional hyponatremia in which the plasma sodium levels are lowered. SIADH may present with euvolemic hyponatremia with continued urinary sodium excretion. Urine osmolality is usually higher than serum osmolality. Very low serum sodium levels can lead to cerebral edema or seizures. Other symptoms of SIADH include fatigue, confusion, muscle weakness, nausea, vomiting, lack of appetite, and weight loss. Treatment usually involves fluid restriction, salt tablets, IV hypertonic saline, diuretics, and drugs like conivaptan, tolvaptan, or demeclocycline.